Treatment Pah and Pulmonary Hypertension

Ads
related to: Treatment Pah and Pulmonary Hypertension
PAH Treatment Option - Prescription Treatment Website

pah-treatment.com
Learn About a Treatment Option to Help Manage PAH. Visit HCP Site. Watch Video to Learn How to Use Potential Treatment for PAH.
Adverse Reactions · Patient Enrollment Form · Oral Treatment · Download Resources
Treatment Recommendations
Learn About the Latest

PAH Treatment Recommendations.

Adverse Reactions
Review the adverse reactions of

this PAH treatment.

Dose Adjustment Support
Learn about how to help support

your patients during titration.

Long-Term Study
Read Data From

Long-term Follow-Up.

Combo Therapy Subgroup
Clinical trial subgroup results

of patients on combo therapy.

Starting Treatment
Learn about treatment dosing

and administration.
PAH Treatment Option - Treatment For PAH (Group 1)

www.pah-hcp.com
Read Potential Drug Interactions. See If PAH Treatment Is Right For Your Adult Patients. Before Prescribing A PAH Treatment Option, Review Important Safety Information.
Resources For Patients · Financial Assistance Info · Enroll Now · View Clinical Data
Treatment Information
Identifying PAH Patients
PAH Basics
Dosing & Administration

Search results

- Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
  Pharmaceutical Technology via Yahoo Finance· 4 days ago
  “We are particularly thrilled that this collaboration enables seralutinib to move directly into a...
- Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
  Benzinga via AOL· 5 days ago
  This global collaboration combines the strengths of both Chiesi and Gossamer to support ongoing work...
- Merck Supports PAH Patients With Unbranded Campaign -- And New Drug
  MediaPost· 2 weeks ago
  Patients can “Outnumber PAH” by developing a strong support team, advises an unbranded educational campaign launched by Merck against pulmonary arterial hypertension (< ...
- Gossamer Bio reports positive phase 2 trial results for PAH treatment By Investing.com
  Investing.com· 1 week ago
  Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company, has announced the...
- Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
  Zacks· 1 day ago
  Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
- Insmed stock target raised on positive trial results By Investing.com
  Investing.com· 2 days ago
  On Thursday, Morgan Stanley (NYSE:MS) showed a positive stance on Insmed (NASDAQ:INSM) Incorporated...
- Chiesi buys into Gossamer’s Winrevair rival, betting almost $500M
  FierceBiotech· 5 days ago
  Italian pharma Chiesi is betting almost $500 million on Gossamer Bio's pulmonary arterial...
- Gossamer sells rights to drug it hopes can rival a new Merck therapy
  BioPharma Dive via Yahoo Finance· 5 days ago
  One analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
- United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
  Insider Monkey via Yahoo Finance· 1 week ago
  United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript May 1, 2024 United...
- United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
  GuruFocus.com via Yahoo Finance· 1 week ago
  While primarily serving the U.S. market, United Therapeutics also offers a pediatric oncology drug, maintaining a strong emphasis on PAH treatments. Financial ...